$IBRX
ImmunityBio, Inc.

2016 Q1 Form 10-K Financial Statement

#000156459016015596 Filed on March 30, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015 Q1
Revenue $6.000K $15.00K $120.0K
YoY Change -95.0% -84.69% -58.04%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $26.67M $25.84M $31.62M
YoY Change -15.66% 1315.01% 3087.3%
% of Gross Profit
Research & Development $4.955M $5.110M $600.0K
YoY Change 725.83% 467.78% 400.0%
% of Gross Profit
Depreciation & Amortization $485.0K $490.0K $26.00K
YoY Change 1765.38% -545.45% -16.13%
% of Gross Profit
Operating Expenses $31.62M $29.94M $32.22M
YoY Change -1.86% 996.63% 2797.57%
Operating Profit -$31.62M -$29.92M -$32.10M
YoY Change -1.51% 1036.89% 3786.32%
Interest Expense $0.00 $2.890M -$850.0K
YoY Change -100.0% -2508.33% 226.92%
% of Operating Profit
Other Income/Expense, Net $796.0K -$90.00K -$747.0K
YoY Change -206.56%
Pretax Income -$30.82M -$77.12M -$32.85M
YoY Change -6.17% 2714.6% 2731.72%
Income Tax -$143.0K -$300.0K $1.000K
% Of Pretax Income
Net Earnings -$30.68M -$26.82M -$32.85M
YoY Change -6.61% 873.58% 2916.44%
Net Earnings / Revenue -511283.33% -178813.33% -27374.17%
Basic Earnings Per Share
Diluted Earnings Per Share -$376.1K -$946.9K -$537.3K
COMMON SHARES
Basic Shares Outstanding 81.93M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $221.8M $294.2M $49.90M
YoY Change 344.49% 397.77%
Cash & Equivalents $63.25M $175.9M $49.85M
Short-Term Investments $158.5M $118.3M
Other Short-Term Assets $190.0K $0.00 $100.0K
YoY Change 90.0% -100.0%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $225.5M $297.5M $50.00M
YoY Change 351.0% 401.14%
LONG-TERM ASSETS
Property, Plant & Equipment $8.200M $5.523M $200.0K
YoY Change 4000.0% 2517.54%
Goodwill
YoY Change
Intangibles $7.292M
YoY Change 773.29%
Long-Term Investments $116.2M $55.10M $0.00
YoY Change 27450.0%
Other Assets $200.0K $1.359M $300.0K
YoY Change -33.33% 232.27%
Total Long-Term Assets $131.9M $69.31M $8.500M
YoY Change 1451.76% 4663.51%
TOTAL ASSETS
Total Short-Term Assets $225.5M $297.5M $50.00M
Total Long-Term Assets $131.9M $69.31M $8.500M
Total Assets $357.4M $366.8M $58.50M
YoY Change 510.94% 503.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.100M $2.085M $1.200M
YoY Change -8.33% 84.35%
Accrued Expenses $4.700M $2.575M $300.0K
YoY Change 1466.67% 727.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.858M $6.148M $2.600M
YoY Change 202.23% 226.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.000M $0.00 $500.0K
YoY Change 700.0% -100.0%
Total Long-Term Liabilities $4.000M $0.00 $500.0K
YoY Change 700.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.858M $6.148M $2.600M
Total Long-Term Liabilities $4.000M $0.00 $500.0K
Total Liabilities $12.93M $10.85M $3.100M
YoY Change 317.03% 351.31%
SHAREHOLDERS EQUITY
Retained Earnings $31.00M -$250.4M
YoY Change 1865.12%
Common Stock $625.2M $606.6M
YoY Change 752.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $344.5M $356.0M $55.40M
YoY Change
Total Liabilities & Shareholders Equity $357.4M $366.8M $58.50M
YoY Change 510.99% 503.09%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015 Q1
OPERATING ACTIVITIES
Net Income -$30.68M -$26.82M -$32.85M
YoY Change -6.61% 873.58% 2916.44%
Depreciation, Depletion And Amortization $485.0K $490.0K $26.00K
YoY Change 1765.38% -545.45% -16.13%
Cash From Operating Activities -$8.860M -$10.95M -$7.370M
YoY Change 20.22% 317.94% 8088.89%
INVESTING ACTIVITIES
Capital Expenditures $1.067M -$950.0K $38.00K
YoY Change 2707.89% -9600.0%
Acquisitions $1.818M
YoY Change
Other Investing Activities -$100.9M -$171.2M -$1.820M
YoY Change 5441.21%
Cash From Investing Activities -$101.9M -$172.1M -$1.860M
YoY Change 5379.03% -1721300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.550M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.890M 300.0K -20.00K
YoY Change 9350.0% -99.49% -88.24%
NET CHANGE
Cash From Operating Activities -8.860M -10.95M -7.370M
Cash From Investing Activities -101.9M -172.1M -1.860M
Cash From Financing Activities -1.890M 300.0K -20.00K
Net Change In Cash -112.7M -182.8M -9.250M
YoY Change 1117.95% -426.84% 3457.69%
FREE CASH FLOW
Cash From Operating Activities -$8.860M -$10.95M -$7.370M
Capital Expenditures $1.067M -$950.0K $38.00K
Free Cash Flow -$9.927M -$10.00M -$7.408M
YoY Change 34.0% 280.23% 8131.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175908000
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015Q4 nk Receivables Prepaid Expense And Other Assets Current
ReceivablesPrepaidExpenseAndOtherAssetsCurrent
3322000
CY2014Q4 nk Receivables Prepaid Expense And Other Assets Current
ReceivablesPrepaidExpenseAndOtherAssetsCurrent
269000
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
118310000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
409000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1131000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
311000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1884000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
228000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1165000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
606555000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
71158000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-192000
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-684000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
797105
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-2047000
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-192000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-237068000
CY2015 nk Stock Issuance Costs
StockIssuanceCosts
28000
CY2012Q4 nk Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
-4394000
CY2013 nk Issuance Of Convertible Preferred Stock Value
IssuanceOfConvertiblePreferredStockValue
511000
CY2013 nk Conversion Of Debt And Payables To Common Stock Value
ConversionOfDebtAndPayablesToCommonStockValue
950000
CY2013 nk Exercise Of Common Stock
ExerciseOfCommonStock
341000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
884000
CY2013Q4 nk Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
-3755000
CY2014 nk Exercise Of Common Stock
ExerciseOfCommonStock
1185000
CY2014 nk Issuance Of Convertible Preferred Stock Value
IssuanceOfConvertiblePreferredStockValue
6701000
CY2014 nk Conversion Of Debt And Payables To Common Stock Value
ConversionOfDebtAndPayablesToCommonStockValue
1339000
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81930998
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8246028
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6185000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2047000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1359000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2085000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2575000
CY2015Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1352000
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
442000
CY2015Q4 nk Build To Suit Lease Liability Noncurrent
BuildToSuitLeaseLiabilityNoncurrent
2468000
CY2015 us-gaap Revenues
Revenues
236000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6148000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
136000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
845000
CY2015Q3 dei Entity Public Float
EntityPublicFloat
961500000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59104000
CY2015 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
521000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
180000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-301000
CY2015 us-gaap Investment Income Net
InvestmentIncomeNet
2988000
CY2013 us-gaap Revenues
Revenues
600000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11434000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1595000
CY2014 us-gaap Revenues
Revenues
641000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
562000
CY2014 us-gaap Investment Income Net
InvestmentIncomeNet
20000
CY2013 us-gaap Investment Income Net
InvestmentIncomeNet
2000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1366000
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
158000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-236876000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-6185000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
227000
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57337000
CY2014Q4 nk Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
57591000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
878000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
211221000
CY2015 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
2415000
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5170000
CY2015 nk Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
7348000
CY2015 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4798000
CY2015 nk Reclassification Of Warrant Liabilities Due To Exercise
ReclassificationOfWarrantLiabilitiesDueToExercise
1543000
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-192000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
355995000
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
60000
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
60000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
211221000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
789000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
884000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-302000
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
377000
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
259000
CY2014 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-115000
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25000
CY2015 nk Non Cash Interest Items From Operating Activities
NonCashInterestItemsFromOperatingActivities
72000
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-56000
CY2015 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
38000
CY2015 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
2501000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
133000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-75000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-95000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
173000
CY2014 us-gaap Increase Decrease In Notes Receivable Related Parties Current
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent
1000
CY2013 us-gaap Increase Decrease In Notes Receivable Related Parties Current
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent
2000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3306000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-97000
CY2015 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1194000
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
160000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
627000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-347000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
700000
CY2015 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1991000
CY2014 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-314000
CY2013 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
309000
CY2015 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1352000
CY2015 nk Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
850000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-113000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-52000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-75000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2241000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
235000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1818000
CY2015 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
198068000
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
26903000
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
316452000
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
63118000
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
676000
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
132000
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1162000
CY2014 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
53000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
317333000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
64407000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
905000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
116804000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
58754000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
234000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
350000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116000
CY2014 us-gaap Interest Paid Net
InterestPaidNet
52000
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
230000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
878000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
180000
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7348000
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4798000
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2415000
CY2013 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
CY2014 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1339000
CY2013 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
950000
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1000000
CY2014 nk Price Change In Par Value
PriceChangeInParValue
1000
CY2014 nk Conversion Of Accounts Payable Against Note Receivable Related Party
ConversionOfAccountsPayableAgainstNoteReceivableRelatedParty
23000
CY2013 nk Conversion Of Accounts Payable Against Note Receivable Related Party
ConversionOfAccountsPayableAgainstNoteReceivableRelatedParty
110000
CY2015 nk Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
1543000
CY2015 nk Estimated Fair Market Value Of Building Under Build To Suit Lease
EstimatedFairMarketValueOfBuildingUnderBuildToSuitLease
2740000
CY2015 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
457000
CY2015 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
182000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015 us-gaap Reclassifications
Reclassifications
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The Company has reclassified certain prior period amounts to conform to the current period presentation. Specifically, it has classified its royalties and cost of licensing to selling, general and administrative expenses. As of December 31, 2014 and 2013, $0.2 million of royalties and cost of licensing expense were reclassified into selling, general and administrative expenses for both periods. The reclassification had no impact on the Company&#8217;s net loss from operations or consolidated stockholders&#8217; equity as previously reported.</p></div>
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to the valuation of warrants, stock-based compensation, the valuation allowance for deferred tax assets, the valuation of build-to-suit lease assets. The Company bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p></div>
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Risks and Uncertainties</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Appeal of USPTO Decision</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2009, the Company received a final rejection in one of the Company&#8217;s original patent applications pertaining to certain limited methods of use claims for NK-92 from the U.S. Patent and Trademark Office (the USPTO) (but the USPTO allowed claims on all of the other proposed claims, including other methods of use). The Company appealed this decision with the USPTO Board of Appeals and, in the fall of 2013, the Board of Appeals reversed the Examiner&#8217;s rejection of the claim to certain limited methods of use with NK-92, but affirmed the Examiner&#8217;s rejection of the remaining patent claims. In December 2013, the Company brought an action in the U.S. District Court for the Eastern District of Virginia to review the decision of the USPTO as the Company disagreed with the decision as to the certain limited non-allowed claims. On September 2, 2015, the U.S. District Court granted the USPTO&#8217;s motion for summary judgment. The Company has filed a notice of appeal and will be appealing the decision. Based on information available at present, the Company cannot reasonably estimate a range of loss for this action.&nbsp;&nbsp;Accordingly, no liability associated with this action has been accrued.&nbsp;&nbsp;The Company is expensing legal costs associated with defending this litigation as the costs are incurred.</p></div>
CY2015 nk Cash And Cash Equivalents Original Maturities
CashAndCashEquivalentsOriginalMaturities
P3M
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6989347
CY2015 nk Maximum Original Maturity Period Of Short Term Marketable Securities
MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities
P12M
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9754461
CY2012Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
57000
CY2015 nk Minimum Original Maturity Period Of Long Term Marketable Securities
MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities
P12M
CY2015 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2012Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
200000
CY2012Q2 nk Percentage Of Outstanding Shares Acquired
PercentageOfOutstandingSharesAcquired
0.222
CY2014Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2015 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015Q4 nk Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories
FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
0
CY2014Q4 nk Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories
FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
0
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27727147
CY2012Q2 nk Business Acquisition Percentage Of Fully Diluted Shares Acquired
BusinessAcquisitionPercentageOfFullyDilutedSharesAcquired
0.174
CY2015Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
911000
CY2015Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
646000
CY2015Q4 nk Prepaid Services
PrepaidServices
631000
CY2014Q4 nk Prepaid Services
PrepaidServices
115000
CY2015Q4 us-gaap Prepaid Insurance
PrepaidInsurance
466000
CY2014Q4 us-gaap Prepaid Insurance
PrepaidInsurance
9000
CY2015Q4 nk Prepaid Legal Fees
PrepaidLegalFees
350000
CY2015Q4 us-gaap Due From Related Parties
DueFromRelatedParties
217000
CY2015Q4 nk Prepaid License Fees
PrepaidLicenseFees
101000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
145000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5690000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
46000
CY2015Q4 nk Equipment Not Placed In Service
EquipmentNotPlacedInService
624000
CY2015Q4 nk Software License And Implementation Costs
SoftwareLicenseAndImplementationCosts
391000
CY2015Q4 us-gaap Security Deposit
SecurityDeposit
344000
CY2014Q4 us-gaap Security Deposit
SecurityDeposit
19000
CY2014Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
249000
CY2014Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
141000
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8636000
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1344000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7292000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1359000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
367000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
91000
CY2015Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
348000
CY2014Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
191000
CY2015Q4 nk Accrued Franchise And Property Taxes
AccruedFranchiseAndPropertyTaxes
225000
CY2015Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
132000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
144000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29000
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
312000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
20000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2015 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-38000
CY2015 us-gaap Investment Income Dividend
InvestmentIncomeDividend
213000
CY2015 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
2501000
CY2015 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2013 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2015 nk Available For Sale Securities Maturity Period
AvailableForSaleSecuritiesMaturityPeriod
P3Y6M
CY2014 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2015Q4 nk Available For Sale Securities Amortized Cost Current
AvailableForSaleSecuritiesAmortizedCostCurrent
136450000
CY2015Q4 nk Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Current
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
15000
CY2015Q4 nk Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Current
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent
116000
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
136349000
CY2015Q4 nk Available For Sale Securities Amortized Cost Non Current
AvailableForSaleSecuritiesAmortizedCostNonCurrent
55226000
CY2015Q4 nk Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Noncurrent
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent
1000
CY2015Q4 nk Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Noncurrent
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent
92000
CY2015Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
55135000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
191676000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
16000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
208000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
191484000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
0
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
152267000
CY2015 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses
208000
CY2015 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
2500000
CY2015Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
191484000
CY2015Q4 us-gaap Cash
Cash
157900000
CY2014Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
177000
CY2014Q4 us-gaap Cash
Cash
59100000
CY2015Q2 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00
CY2014 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00
CY2015Q2 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.800
CY2014 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.795
CY2015Q2 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0143
CY2014 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0167
CY2015Q2 nk Fair Value Assumptions Marketability Discount
FairValueAssumptionsMarketabilityDiscount
0.100
CY2014 nk Fair Value Assumptions Marketability Discount
FairValueAssumptionsMarketabilityDiscount
0.100
CY2014Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
177000
CY2015 nk Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
1543000
CY2015Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
130000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2015 nk Warrant Exercise Term
WarrantExerciseTerm
P10Y
CY2015 nk Exchange Of Warrants For Options Exercisable
ExchangeOfWarrantsForOptionsExercisable
37030
CY2014Q1 nk Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
3000000
CY2014Q1 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
0.07
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
19115000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1094000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two And Three Years
OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears
5638000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four And Five Years
OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears
5928000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
6455000
CY2015Q4 nk License Agreement Obligations
LicenseAgreementObligations
1311000
CY2015Q4 nk License Agreement Obligations Due In Two And Three Years
LicenseAgreementObligationsDueInTwoAndThreeYears
437000
CY2015Q4 nk License Agreement Obligations Due In Four And Five Years
LicenseAgreementObligationsDueInFourAndFiveYears
874000
CY2015Q4 us-gaap Contractual Obligation
ContractualObligation
20426000
CY2015Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1094000
CY2015Q4 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
6075000
CY2015Q4 us-gaap Contractual Obligation Due In Fourth And Fifth Year
ContractualObligationDueInFourthAndFifthYear
6802000
CY2015Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
6455000
CY2015 nk Agreement Effective Date
AgreementEffectiveDate
2015-08-01
CY2015 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.8515
CY2015Q4 nk Share Based Compensation Common Stock Issuance For Future And Forfeitures In Period
ShareBasedCompensationCommonStockIssuanceForFutureAndForfeituresInPeriod
947063
CY2015Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2126682
CY2015Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
71000000
CY2015Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
7000000
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9531200
CY2015Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
221500000
CY2015Q3 nk Underwriting Discounts Commissions And Offering Expenses
UnderwritingDiscountsCommissionsAndOfferingExpenses
16800000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
211221000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
789000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
884000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4249857
CY2015 nk Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsGrantsInPeriod
3070238
CY2015 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.038
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1427000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2014 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.073
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
208000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1000
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-302000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
67559000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
121000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
572000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
75000
CY2013 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
-0.002
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
2000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
389000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
10000
CY2015Q4 nk Deferred Tax Assets Deferred Depreciation And Amortization
DeferredTaxAssetsDeferredDepreciationAndAmortization
624000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
69144000
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
1165000
CY2014Q4 nk Deferred Tax Liabilities Deferred Depreciation And Amortization
DeferredTaxLiabilitiesDeferredDepreciationAndAmortization
46000
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1165000
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.026
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.048
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.120
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
46000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
67979000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
162000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
69144000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
162000
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1165000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.000
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.005
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.000
CY2015 nk Effective Income Tax Reconciliation Change In Net Operating Loss Percentage
EffectiveIncomeTaxReconciliationChangeInNetOperatingLossPercentage
-0.035
CY2014 nk Effective Income Tax Reconciliation Change In Net Operating Loss Percentage
EffectiveIncomeTaxReconciliationChangeInNetOperatingLossPercentage
-0.400
CY2013 nk Effective Income Tax Reconciliation Change In Net Operating Loss Percentage
EffectiveIncomeTaxReconciliationChangeInNetOperatingLossPercentage
-0.323
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.001
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.007
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.000
CY2015 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
-0.004
CY2014 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
-0.011
CY2013 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
0.000
CY2015 nk Effective Income Tax Rate Reconciliation Warrant Derivative Liability Adjustment
EffectiveIncomeTaxRateReconciliationWarrantDerivativeLiabilityAdjustment
0.000
CY2014 nk Effective Income Tax Rate Reconciliation Warrant Derivative Liability Adjustment
EffectiveIncomeTaxRateReconciliationWarrantDerivativeLiabilityAdjustment
0.000
CY2013 nk Effective Income Tax Rate Reconciliation Warrant Derivative Liability Adjustment
EffectiveIncomeTaxRateReconciliationWarrantDerivativeLiabilityAdjustment
-0.201
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.289
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.084
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.052
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2015 nk Research And Development Cumulative Change In Ownership Percentage
ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage
0.50
CY2015 nk Period Of Cumulative Ownership Change
PeriodOfCumulativeOwnershipChange
P3Y
CY2015 us-gaap Research And Development Arrangement With Federal Government Costs Incurred Net
ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet
12700000
CY2014 us-gaap Research And Development Arrangement With Federal Government Costs Incurred Net
ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet
4000000
CY2015 nk Research And Development Arrangement With State Government Costs Incurred Net
ResearchAndDevelopmentArrangementWithStateGovernmentCostsIncurredNet
12700000
CY2014 nk Research And Development Arrangement With State Government Costs Incurred Net
ResearchAndDevelopmentArrangementWithStateGovernmentCostsIncurredNet
4000000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
40000
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
69000000
CY2015Q4 nk Unrealized Excess Tax Benefits Associated With Share Based Compensation
UnrealizedExcessTaxBenefitsAssociatedWithShareBasedCompensation
40000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2015 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
120000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1083000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1203000
CY2015Q4 nk Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate
800000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
227678000
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.31
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4621000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2423000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-175224000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-25305000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.57
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1472000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5418000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-235000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-668000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3000
CY2015Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25838000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-26822000
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31618000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-32849000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2014Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1826000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-2755000
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
724000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-918000
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1079000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1423000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
992000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1089000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
us-gaap Net Income Loss
NetIncomeLoss
-160110000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
981000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14361000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3104000
us-gaap Net Income Loss
NetIncomeLoss
-117470000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
986000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10162000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
483000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2453000
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7372000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1856000
us-gaap Net Income Loss
NetIncomeLoss
-3430000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
79000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2844000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-205000
us-gaap Net Income Loss
NetIncomeLoss
-2512000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2091000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-17000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31000
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-38000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2000
CY2015Q1 us-gaap Revenues
Revenues
120000
CY2015Q2 us-gaap Revenues
Revenues
91000
CY2015Q3 us-gaap Revenues
Revenues
10000
CY2015Q4 us-gaap Revenues
Revenues
15000
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61137625
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65789041
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
77837586
CY2015Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81247430
CY2014Q1 us-gaap Revenues
Revenues
286000
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31290625
CY2014Q2 us-gaap Revenues
Revenues
124000
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2880748
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7543348
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7903941
CY2014Q3 us-gaap Revenues
Revenues
133000
CY2014Q4 us-gaap Revenues
Revenues
98000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1112000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
1322000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
1052000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
2730000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-826000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1198000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-919000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2632000

Files In Submission

Name View Source Status
0001564590-16-015596-index-headers.html Edgar Link pending
0001564590-16-015596-index.html Edgar Link pending
0001564590-16-015596.txt Edgar Link pending
0001564590-16-015596-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
genqdop3r2rl000001.jpg Edgar Link pending
genqdop3r2rl000002.jpg Edgar Link pending
genqdop3r2rl000003.jpg Edgar Link pending
genqdop3r2rl000004.jpg Edgar Link pending
genqdop3r2rl000005.jpg Edgar Link pending
genqdop3r2rl000006.jpg Edgar Link pending
genqdop3r2rl000007.jpg Edgar Link pending
genqdop3r2rl000008.jpg Edgar Link pending
genqdop3r2rl000009.jpg Edgar Link pending
genqdop3r2rl000010.jpg Edgar Link pending
genqdop3r2rl000011.jpg Edgar Link pending
genqdop3r2rl000012.jpg Edgar Link pending
genqdop3r2rl000013.jpg Edgar Link pending
genqdop3r2rl000014.jpg Edgar Link pending
genqdop3r2rl000015.jpg Edgar Link pending
genqdop3r2rl000016.jpg Edgar Link pending
genqdop3r2rl000017.jpg Edgar Link pending
genqdop3r2rl000018.jpg Edgar Link pending
genqdop3r2rl000019.jpg Edgar Link pending
genqdop3r2rl000020.jpg Edgar Link pending
genqdop3r2rl000021.jpg Edgar Link pending
gojvojtsz3nh000001.jpg Edgar Link pending
gr0yglebykgs000001.jpg Edgar Link pending
grprtsjbwide000001.jpg Edgar Link pending
nk-10k_20151231.htm Edgar Link pending
nk-20151231.xml Edgar Link completed
nk-20151231.xsd Edgar Link pending
nk-20151231_cal.xml Edgar Link unprocessable
nk-20151231_def.xml Edgar Link unprocessable
nk-20151231_lab.xml Edgar Link unprocessable
nk-20151231_pre.xml Edgar Link unprocessable
nk-ex1021_1731.htm Edgar Link pending
nk-ex1022_1730.htm Edgar Link pending
nk-ex1023_1729.htm Edgar Link pending
nk-ex181_1728.htm Edgar Link pending
nk-ex211_1727.htm Edgar Link pending
nk-ex231_1732.htm Edgar Link pending
nk-ex311_11.htm Edgar Link pending
nk-ex312_10.htm Edgar Link pending
nk-ex321_9.htm Edgar Link pending
nk-ex322_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending